College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, Gansu, China.
Technology and Research Center of Gansu Province for Embryonic Engineering of Bovine and Sheep & Goat, Lanzhou, Gansu, China.
Front Cell Infect Microbiol. 2022 Sep 16;12:984537. doi: 10.3389/fcimb.2022.984537. eCollection 2022.
In order to evaluate the potential and safety of lactic acid bacteria (LAB) isolated from faeces samples of Ganan yak as probiotic for prevention and/or treatment of yak diarrhea, four strains of LAB including (FY1), Weissella cibaria (FY2), (FY3), and (FY4) were isolated and identified in this study. Cell surface characteristics (hydrophobicity and cell aggregation), acid resistance and bile tolerance, compatibility, antibacterial activity and cell adhesion tests were also carried out to evaluate the probiotic potential of LAB. The results showed that the four isolates had certain acid tolerance, bile salt tolerance, hydrophobicity and cell aggregation, all of which contribute to the survival and colonization of LAB in the gastrointestinal tract. There is no compatibility between the four strains, so they can be combined into a mixed probiotic formula. Antimicrobial tests showed that the four strains were antagonistic to , , and . Moreover, the safety of the four isolates were determined through hemolytic analysis, gelatinase activity, and antibacterial susceptibility experiments. The results suggest that all the four strains were considered as safe because they had no hemolytic activity, no gelatinase activity and were sensitive to most antibacterial agents. Moreover, the acute oral toxicity test of LAB had no adverse effect on body weight gain, food utilization and organ indices in Kunming mice. In conclusion, the four LAB isolated from yak feces have considerable potential to prevent and/or treat yak bacterial disease-related diarrhea.
为评估从Ganang 牦牛粪便样本中分离的乳酸菌(LAB)作为预防和/或治疗牦牛腹泻的益生菌的潜力和安全性,本研究分离并鉴定了 4 株 LAB,包括(FY1)、魏斯氏菌(FY2)、(FY3)和(FY4)。还进行了细胞表面特性(疏水性和细胞聚集)、耐酸和耐胆盐、相容性、抗菌活性和细胞黏附试验,以评估 LAB 的益生菌潜力。结果表明,这 4 个分离株具有一定的耐酸、耐胆盐、疏水性和细胞聚集性,所有这些都有助于 LAB 在胃肠道中的存活和定植。这 4 株菌之间没有相容性,因此可以将它们组合成一种混合益生菌配方。抗菌试验表明,这 4 株菌对、和具有拮抗作用。此外,通过溶血分析、明胶酶活性和抗菌药敏试验确定了这 4 株菌的安全性。结果表明,由于这 4 株菌均无溶血活性、无明胶酶活性且对大多数抗菌药物敏感,因此被认为是安全的。此外,LAB 的急性口服毒性试验对昆明小鼠的体重增加、食物利用率和器官指数均无不良影响。综上所述,从牦牛粪便中分离的 4 株 LAB 具有预防和/或治疗牦牛细菌性疾病相关腹泻的巨大潜力。